Compensated cirrhosis: natural history and prognostic factors
- PMID: 3804191
- DOI: 10.1002/hep.1840070124
Compensated cirrhosis: natural history and prognostic factors
Abstract
To investigate the natural history of compensated cirrhosis, 293 consecutive patients without previous major complications (ascites, jaundice, encephalopathy or gastrointestinal hemorrhage) were studied in terms of morbidity (probability of developing decompensated cirrhosis during follow-up) and survival. Patients were diagnosed by liver histology between 1968 and 1980. Median follow-up was 63 months. Decompensation of cirrhosis was considered when a patient first developed one of the major complications of the disease. Ten years after diagnosis, the probability of developing decompensated cirrhosis and the survival probability rate were 58 and 47%, respectively. A multivariate survival analysis (Cox's regression model) using clinical, biochemical and histological data obtained at diagnosis disclosed seven factors that predicted prognosis: serum bilirubin; serum gamma-globulin concentration; hepatic stigmata; prothrombin time; sex; age, and alkaline phosphatase. According to the contribution of each one of these factors to the final model, a prognostic index was constructed that allows calculation of the estimated survival probability. The predicting value of this index was validated by a split sample testing technique.
Similar articles
-
An analysis of prognostic factors in cirrhosis.Chin Med J (Engl). 1989 Apr;102(4):266-72. Chin Med J (Engl). 1989. PMID: 2507240
-
Survival and prognostic indicators in compensated and decompensated cirrhosis.Dig Dis Sci. 1986 May;31(5):468-75. doi: 10.1007/BF01320309. Dig Dis Sci. 1986. PMID: 3009109
-
Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis.Wien Klin Wochenschr. 2003 May 15;115(9):302-8. doi: 10.1007/BF03040336. Wien Klin Wochenschr. 2003. PMID: 12793031
-
Prognostic significance of hepatic encephalopathy in patients with cirrhosis.J Hepatol. 1999 May;30(5):890-5. doi: 10.1016/s0168-8278(99)80144-5. J Hepatol. 1999. PMID: 10365817
-
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis.Hepatol Int. 2018 Feb;12(Suppl 1):34-43. doi: 10.1007/s12072-017-9808-z. Epub 2017 Jul 5. Hepatol Int. 2018. PMID: 28681347 Review.
Cited by
-
Continuous furosemide infusion in the management of ascites.J Investig Med. 2012 Apr;60(4):671-5. doi: 10.2310/JIM.0b013e31824963f1. J Investig Med. 2012. PMID: 22373660 Free PMC article.
-
Palliative care for patients with end-stage liver disease.Curr Gastroenterol Rep. 2015 May;17(5):440. doi: 10.1007/s11894-015-0440-6. Curr Gastroenterol Rep. 2015. PMID: 25855211 Review.
-
Clinical manifestations of portal hypertension.Int J Hepatol. 2012;2012:203794. doi: 10.1155/2012/203794. Epub 2012 Sep 17. Int J Hepatol. 2012. PMID: 23024865 Free PMC article.
-
Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.PLoS One. 2016 Jun 14;11(6):e0155822. doi: 10.1371/journal.pone.0155822. eCollection 2016. PLoS One. 2016. PMID: 27299728 Free PMC article.
-
Reexamining the data used in the 2012 guidelines of the American Association for the Study of Liver Diseases for the management of adult patients with ascites due to cirrhosis.Ann Gastroenterol. 2019 Nov-Dec;32(6):642-649. doi: 10.20524/aog.2019.0415. Epub 2019 Sep 23. Ann Gastroenterol. 2019. PMID: 31700243 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical